about
Success of rogue online pharmacies: sewage study of sildenafil in the NetherlandsMass spectrometric strategies for the investigation of biomarkers of illicit drug use in wastewater.Facilitating high resolution mass spectrometry data processing for screening of environmental water samples: An evaluation of two deconvolution tools.Spatial differences and temporal changes in illicit drug use in Europe quantified by wastewater analysisEnantiomer profiling of high loads of amphetamine and MDMA in communal sewage: a Dutch perspective.Asymmetrical flow field-flow fractionation hyphenated to Orbitrap high resolution mass spectrometry for the determination of (functionalised) aqueous fullerene aggregates.Size and concentration determination of (functionalised) fullerenes in surface and sewage water matrices using field flow fractionation coupled to an online accurate mass spectrometer: method development and validation.Determination of phosphodiesterase type V inhibitors in wastewater by direct injection followed by liquid chromatography coupled to tandem mass spectrometry.Comparative measurement and quantitative risk assessment of alcohol consumption through wastewater-based epidemiology: An international study in 20 cities.Qualitative screening of new psychoactive substances in pooled urine samples from Belgium and United Kingdom.Sample preparation for combined chemical analysis and in vitro bioassay application in water quality assessment.Analysis of fullerenes in soils samples collected in The Netherlands.Is there evidence for man-made nanoparticles in the Dutch environment?Comparing illicit drug use in 19 European cities through sewage analysis.Risk assessment for drugs of abuse in the Dutch watercycle.An analytical method for determination of fullerenes and functionalized fullerenes in soils with high performance liquid chromatography and UV detection.Surface and wastewater quality monitoring: combination of liquid chromatography with (geno)toxicity detection, diode array detection and tandem mass spectrometry for identification of pollutants.Evaluation of uncertainties associated with the determination of community drug use through the measurement of sewage drug biomarkers.Wastewater-based epidemiology generated forensic information: Amphetamine synthesis waste and its impact on a small sewage treatment plant.Analysis of (Functionalized) Fullerenes in Water Samples by Liquid Chromatography Coupled to High-Resolution Mass SpectrometryQuantifying summed fullerene nC60 and related transformation products in water using LC LTQ Orbitrap MS and application to environmental samplesPerformance of the linear ion trap Orbitrap mass analyzer for qualitative and quantitative analysis of drugs of abuse and relevant metabolites in sewage waterDetermination of Illicit Drugs in the Water Cycle by LC-Orbitrap MSSpatio-temporal assessment of illicit drug use at large scale: evidence from 7 years of international wastewater monitoring
P50
Q28243199-A1BB9170-39B6-4B94-B0B1-043FD6FD1C03Q30244453-3E430CE9-CC0F-445E-85AA-94ED86916C8AQ31111088-D3DDDCC4-4FE8-4651-9307-9BADCC4008C1Q34376086-734E60B0-ED84-4CCF-A95C-8C5FB1A37D66Q35056826-0F434277-2252-427A-9107-46B4F165A297Q35202658-B5AC0686-2615-4FE9-B0E2-44A2055162CBQ35595813-5143AF24-9A9D-4EC4-AD16-BCA48796B19CQ36012741-F4C09F83-0752-452E-AC9B-2028EC514EADQ36020162-BC1C1E06-34F1-4B8E-AEBD-F4288ED9711EQ36116811-675AC239-D627-4470-8ADF-440662D3ED5BQ39064586-A2B73D64-8A68-4D02-9DEC-459A294F5113Q39358269-19A5A1CC-124E-4DF8-B509-A645B662B6F7Q40416224-0E9C0267-0E39-4BEF-8C35-57AC6F59291CQ43347266-0C942AB2-DED0-4345-BA69-6F5929E35419Q43354633-F44DD2DC-6C7A-4504-9378-8F1F7EB626ACQ43499860-DA9EF3D9-53FF-4033-96D7-2112ED49BDCAQ44154382-225EDF7B-53FB-4406-A6D9-40BBBDF82418Q48105343-FCCB6BF4-2D6E-444B-91E9-78629123C6A5Q52618281-8005C69A-CE14-4B9D-B074-C37A4D184735Q57199444-E4DC6DDA-BD3B-430B-B11F-C19A50C12F1BQ57199449-3287B9BB-971F-4357-A830-FCE6F23E8148Q57203891-D60EC15B-2313-4A37-A075-6F6753818C2DQ57203899-CAC9E07F-7488-41AA-93A6-ECF1D0FDBDCEQ90896795-CDD9C016-F865-4DAD-AF5B-72FB15D34B46
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-8441-1709
@en
name
Erik Emke
@ast
Erik Emke
@en
Erik Emke
@es
Erik Emke
@nl
type
label
Erik Emke
@ast
Erik Emke
@en
Erik Emke
@es
Erik Emke
@nl
prefLabel
Erik Emke
@ast
Erik Emke
@en
Erik Emke
@es
Erik Emke
@nl
P106
P31
P496
0000-0002-8441-1709